Literature DB >> 21743068

Performance evaluation of paediatric propofol pharmacokinetic models in healthy young children.

P Sepúlveda1, L I Cortínez, C Sáez, A Penna, S Solari, I Guerra, A R Absalom.   

Abstract

BACKGROUND: The performance of eight currently available paediatric propofol pharmacokinetic models in target-controlled infusions (TCIs) was assessed, in healthy children from 3 to 26 months of age.
METHODS: Forty-one, ASA I-II children, aged 3-26 months were studied. After the induction of general anaesthesia with sevoflurane and remifentanil, a propofol bolus dose of 2.5 mg kg(-1) followed by an infusion of 8 mg kg(-1) h(-1) was given. Arterial blood samples were collected at 1, 2, 3, 5, 10, 20, 40, and 60 min post-bolus, at the end of surgery, and at 1, 3, 5, 30, 60, and 120 min after stopping the infusion. Model performance was visually inspected with measured/predicted plots. Median performance error (MDPE) and the median absolute performance error (MDAPE) were calculated to measure bias and accuracy of each model.
RESULTS: Performance of the eight models tested differed markedly during the different stages of propofol administration. Most models underestimated propofol concentration 1 min after the bolus dose, suggesting an overestimation of the initial volume of distribution. Six of the eight models tested were within the accepted limits of performance (MDPE<20% and MDAPE<30%). The model derived by Short and colleagues performed best.
CONCLUSIONS: Our results suggest that six of the eight models tested perform well in young children. Since most models overestimate the initial volume of distribution, the use for TCI might result in the administration of larger bolus doses than necessary.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21743068     DOI: 10.1093/bja/aer198

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  13 in total

1.  Population pharmacokinetic and pharmacodynamic model of propofol externally validated in children.

Authors:  Byung-Moon Choi; Hyun-Gu Lee; Hyo-Jin Byon; Soo-Han Lee; Eun-Kyung Lee; Hee-Soo Kim; Gyu-Jeong Noh
Journal:  J Pharmacokinet Pharmacodyn       Date:  2015-02-28       Impact factor: 2.745

2.  Measuring the accuracy of propofol target-controlled infusion (TCI) before and after surgery with major blood loss.

Authors:  Thomas Mohler; JoEllen Welter; Martina Steurer; Luis Neumann; Max Zueger; Thomas Kraemer; Alexander Dullenkopf
Journal:  J Clin Monit Comput       Date:  2019-01-22       Impact factor: 2.502

3.  Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in gynecologic patients.

Authors:  Takayuki Kunisawa; Akio Yamagishi; Manabu Suno; Susumu Nakade; Ryunosuke Higashi; Atsushi Kurosawa; Ami Sugawara; Kazuo Matsubara; Hiroshi Iwasaki
Journal:  J Anesth       Date:  2014-09-04       Impact factor: 2.078

4.  Evaluation of pharmacokinetic models of intravenous dexmedetomidine in sedated patients under spinal anesthesia.

Authors:  Shinju Obara; Tsuyoshi Imaizumi; Takahiro Hakozaki; Atsuyuki Hosono; Yuzo Iseki; Norie Sanbe; Masahiro Murakawa
Journal:  J Anesth       Date:  2017-11-02       Impact factor: 2.078

5.  Population pharmacokinetics of intravenous acetaminophen in Japanese patients undergoing elective surgery.

Authors:  Tsuyoshi Imaizumi; Shinju Obara; Midori Mogami; Yuzo Iseki; Makiko Hasegawa; Masahiro Murakawa
Journal:  J Anesth       Date:  2017-04-21       Impact factor: 2.078

6.  The predictive ability of six pharmacokinetic models of rocuronium developed using a single bolus: evaluation with bolus and continuous infusion regimen.

Authors:  Tomoki Sasakawa; Kenichi Masui; Tomiei Kazama; Hiroshi Iwasaki
Journal:  J Anesth       Date:  2016-04-20       Impact factor: 2.078

7.  Target-controlled infusion and population pharmacokinetics of landiolol hydrochloride in patients with peripheral arterial disease.

Authors:  Takayuki Kunisawa; Akio Yamagishi; Manabu Suno; Susumu Nakade; Naoki Honda; Atsushi Kurosawa; Ami Sugawara; Yoshikazu Tasaki; Hiroshi Iwasaki
Journal:  Ther Clin Risk Manag       Date:  2015-01-17       Impact factor: 2.423

Review 8.  Why do We Use the Concepts of Adult Anesthesia Pharmacology in Developing Brains? Will It Have an Impact on Outcomes? Challenges in Neuromonitoring and Pharmacology in Pediatric Anesthesia.

Authors:  Pablo O Sepúlveda; Valeria Epulef; Gustavo Campos
Journal:  J Clin Med       Date:  2021-05-18       Impact factor: 4.241

9.  The administration of high-dose propofol sedation with manual and target-controlled infusion in children undergoing radiation therapy: a 7-year clinical investigation.

Authors:  Tak Kyu Oh; Seung Jae Lee; Jae Hyun Kim; Boram Park; Woosik Eom
Journal:  Springerplus       Date:  2016-03-25

Review 10.  Clinical Pharmacokinetics and Pharmacodynamics of Propofol.

Authors:  Marko M Sahinovic; Michel M R F Struys; Anthony R Absalom
Journal:  Clin Pharmacokinet       Date:  2018-12       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.